Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry ran
- PDF / 1,769,084 Bytes
- 17 Pages / 595.276 x 790.866 pts Page_size
- 27 Downloads / 181 Views
RESEARCH ARTICLE
Open Access
Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT) Peter O’Halloran1* , Helen Noble1, Kelly Norwood2, Peter Maxwell3,4, Fliss Murtagh5, Joanne Shields4, Robert Mullan6, Michael Matthews1,6, Christopher Cardwell7, Mike Clarke7, Rachael Morton8, Karan Shah8, Trisha Forbes1 and Kevin Brazil1
Abstract Background: Advance Care Planning is recommended for people with end-stage kidney disease but evidence is limited. Robust clinical trials are needed to investigate the impact of advance care planning in this population. There is little available data on cost-effectiveness to guide decision makers in allocating resources for advance care planning. Therefore we sought to determine the feasibility of a randomised controlled trial and to test methods for assessing cost-effectiveness. Methods: A deferred entry, randomised controlled feasibility trial, incorporating economic and process evaluations, with people with end-stage kidney disease, aged 65 years or older, receiving haemodialysis, in two renal haemodialysis units in Northern Ireland, UK. A nurse facilitator helped the patient make an advance care plan identifying: a surrogate decision-maker; what the participant would like to happen in the future; any advance decision to refuse treatment; preferred place of care at end-of-life. (Continued on next page)
* Correspondence: [email protected] 1 School of Nursing and Midwifery, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
O’Halloran et al. BMC Nephrology
(2020) 21:478
Page 2 of 17
(Continued from previous page)
Results: Recruitment lasted 189 days; intervention and data collection 443 days. Of the 67 patients invited to participate 30
Data Loading...
